Cook Medical Introduces Innovative Aneurysm Therapy Technique In China
This article was originally published in PharmAsia News
Cook Medical recently introduced to Shanghai's major hospitals its innovative aneurysm therapy technique for the surgical treatment of thoracic aorta aneurysms. By inserting a special vascular stent into an aneurysm, the minimally invasive intervention methodology can increase the stability of the surgery. Cook Medical has conducted clinical trials of the technique in German hospitals and results show the therapy can effectively reduce the rate of blood vessel rupture, lowering patient death incidence. At present, China has about 100,000 thoracic aorta aneurysm patients, of whom fewer than 100 get treated. (Click here for more - Chinese Language)
You may also be interested in...
In a bipartisan move, the US Senate is moving to impose new rules on companies - including those from China - seeking US initial public offerings, adding further uncertainty over such plans and further stoking trade tensions.
First-line lung cancer approval will expand potential market for Takeda's ALK contender but the latecomer is also facing some well-established class competition in the setting.
Kynmobi is an important approval for parent company Sumitomo Dainippon ahead of the loss of exclusivity for Latuda. Sunovion hopes to launch after COVID-19 social distancing requirements ease.